Patent · US Expired

Leukaemia inhibitory factor

US5750654A · kind A · utility

5Cited by

5References

6Claims

0Family size

Assignee

AMRAD Corporation Limited · AU

Inventors

David Gearing · Melbourne, AU
Nicholas Martin Gough · Melbourne, AU
Douglas Hilton · Melbourne, AU
Julie Ann King · Melbourne, AU
Donald Metcalf · Melbourne, AU
Edouard Collins Nice · Melbourne, AU
Nicos A. Nicola · Melbourne, AU
Richard J. Simpson · Melbourne, AU
Tracy Willson · Melbourne, AU

Key dates

Filing date	Mar 29, 1995
Grant date	May 12, 1998
Priority date	—
Expiry date	Mar 29, 2015

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/13043
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides isolated DNA molecules encoding human and murine LIF, and methods of producing LIF by the expression of the isolated DNA in suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.